Reckitt Benckiser said it would pursue a demerger of its pharmaceutical division, as the consumer-products maker reported a fall in second-quarter revenue.
from WSJ.com: US Business http://ift.tt/1q7SCxH
via IFTTT
from WSJ.com: US Business http://ift.tt/1q7SCxH
via IFTTT
No comments:
Post a Comment